We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
News Corp Class A
NWSA
$14.5B
| $7.38M | 0.14% |
556,800
+206,800
| +59% | +$2.8M |
|
|
POLY
202
DELISTED
Plantronics, Inc.
POLY
| $7.36M | 0.14% |
166,362
+50,863
| +44% | +$2.34M |
|
|
PAY
203
DELISTED
Verifone Systems Inc
PAY
| $7.35M | 0.14% |
362,408
+33,263
| +10% | +$649K |
|
|
CARB
204
DELISTED
Carbonite Inc
CARB
| $7.32M | 0.14% |
332,842
+32,820
| +11% | +$694K |
|
205
Pinnacle West Capital
PNW
$12.9B
| $7.3M | 0.14% |
86,315
-660
| -0.8% | -$57.8K |
|
|
BRSL
206
Brightstar Lottery PLC
BRSL
$1.93B
| $7.29M | 0.14% |
296,928
+83,748
| +39% | +$1.71M |
|
|
ACOR
207
DELISTED
Acorda Therapeutics
ACOR
| $7.24M | 0.14% |
2,552
-26
| -1% | -$68.5K |
|
|
ATH
208
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $7.15M | 0.14% |
+132,868
| New | +$6.87M |
|
|
TCF
209
DELISTED
TCF Financial Corporation
TCF
| $6.97M | 0.14% |
409,096
-38,370
| -9% | -$605K |
|
210
Insight Enterprises
NSIT
$3.57B
| $6.95M | 0.14% |
151,338
+1,798
| +1% | +$74K |
|
|
BIVV
211
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $6.93M | 0.13% |
+121,463
| New | +$7.11M |
|
212
SPX Corp
SPXC
$11.2B
| $6.91M | 0.13% |
235,454
+6,520
| +3% | +$171K |
|
213
Meta Platforms (Facebook)
META
$1.53T
| $6.88M | 0.13% |
40,286
-1,340
| -3% | -$224K |
|
214
Occidental Petroleum
OXY
$56.8B
| $6.83M | 0.13% |
+106,290
| New | +$6.47M |
|
|
TSE
215
DELISTED
Trinseo
TSE
| $6.82M | 0.13% |
101,699
+10,690
| +12% | +$711K |
|
216
Progress Software
PRGS
$1.56B
| $6.78M | 0.13% |
177,560
+56,418
| +47% | +$1.88M |
|
|
BWLD
217
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $6.75M | 0.13% |
63,824
+42,157
| +195% | +$4.69M |
|
218
TriNet
TNET
$2.84B
| $6.72M | 0.13% |
200,018
+156,447
| +359% | +$5.48M |
|
219
Emergent Biosolutions
EBS
$376M
| $6.65M | 0.13% |
164,403
+13,530
| +9% | +$490K |
|
|
VIAB
220
DELISTED
Viacom Inc. Class B
VIAB
| $6.63M | 0.13% |
238,150
-202,110
| -46% | -$6.23M |
|
|
MGLN
221
DELISTED
Magellan Health Services, Inc.
MGLN
| $6.44M | 0.13% |
74,659
-30,167
| -29% | -$2.38M |
|
222
Adtran
ADTN
$814M
| $6.31M | 0.12% |
263,078
-12,700
| -5% | -$281K |
|
223
Skywest
SKYW
$4.13B
| $6.29M | 0.12% |
143,401
-47,839
| -25% | -$1.79M |
|
224
MasTec
MTZ
$27.4B
| $6.27M | 0.12% |
135,170
+41,240
| +44% | +$1.8M |
|
225
Hancock Whitney
HWC
$6.18B
| $6.23M | 0.12% |
128,580
+53,170
| +71% | +$2.43M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.